Read + Share
Amedeo Smart
Independent Medical Education
Nelson AJ, Pagidipati NJ, Aroda VR, Cavender MA, et al. Incorporating SGLT2i and GLP-1RA for Cardiovascular and Kidney Disease Risk Reduction: Call for Action to the Cardiology Community. Circulation 2021;144:74-84.PMID: 34228476
Email
LinkedIn
Facebook
Twitter
Privacy Policy